檢索結果 - Scott R. Plotkin

Refine Results
  1. 1
    Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis

    Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis 由 Jaishri O. Blakeley, Scott R. Plotkin

    出版 2016
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1

    Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1 由 Anna R. Terry, Justin T. Jordan, Lee H. Schwamm, Scott R. Plotkin

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature

    Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature 由 Ana-Maria Vranceanu, Vanessa L. Merker, Elyse R. Park, Scott R. Plotkin

    出版 2013
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Exacerbation of Cerebral Radiation Necrosis by Bevacizumab

    Exacerbation of Cerebral Radiation Necrosis by Bevacizumab 由 Deva S. Jeyaretna, William T. Curry, Tracy T. Batchelor, Anat Stemmer‐Rachamimov, Scott R. Plotkin

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Glioblastoma care in the elderly

    Glioblastoma care in the elderly 由 Justin T. Jordan, Elizabeth R. Gerstner, Tracy T. Batchelor, Daniel P. Cahill, Scott R. Plotkin

    出版 2015
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    Natural History of Vestibular Schwannoma Growth and Hearing Decline in Newly Diagnosed Neurofibromatosis Type 2 Patients

    Natural History of Vestibular Schwannoma Growth and Hearing Decline in Newly Diagnosed Neurofibromatosis Type 2 Patients 由 Scott R. Plotkin, Vanessa L. Merker, Alona Muzikansky, Fred G. Barker, William H. Slattery

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Clinical Features of Schwannomatosis: A Retrospective Analysis of 87 Patients

    Clinical Features of Schwannomatosis: A Retrospective Analysis of 87 Patients 由 Vanessa L. Merker, Sonia Esparza, Miriam J. Smith, Anat Stemmer‐Rachamimov, Scott R. Plotkin

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Outcomes of hospitalization in pregnant women with CNS neoplasms: a population-based study

    Outcomes of hospitalization in pregnant women with CNS neoplasms: a population-based study 由 Anna R. Terry, Fred G. Barker, Lisa Leffert, Brian T. Bateman, Irene Souter, Scott R. Plotkin

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Erlotinib for Progressive Vestibular Schwannoma in Neurofibromatosis 2 Patients

    Erlotinib for Progressive Vestibular Schwannoma in Neurofibromatosis 2 Patients 由 Scott R. Plotkin, Chris Halpin, Michael J. McKenna, Jay S. Loeffler, Tracy T. Batchelor, Fred G. Barker

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Expression of SMARCB1 (INI1) mutations in familial schwannomatosis

    Expression of SMARCB1 (INI1) mutations in familial schwannomatosis 由 Miriam J. Smith, James A. Walker, Yiping Shen, Anat Stemmer‐Rachamimov, James F. Gusella, Scott R. Plotkin

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome

    Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome 由 Daphne L. Wang, Kelly B. Smith, Sonia Esparza, Fawn A. Leigh, Alona Muzikansky, Elyse R. Park, Scott R. Plotkin

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Bevacizumab for Progressive Vestibular Schwannoma in Neurofibromatosis Type 2

    Bevacizumab for Progressive Vestibular Schwannoma in Neurofibromatosis Type 2 由 Scott R. Plotkin, Vanessa L. Merker, Chris Halpin, Dominique Jennings, Michael J. McKenna, Gordon J. Harris, Fred G. Barker

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2

    Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2 由 Said Farschtschi, Vanessa L. Merker, David S. Wolf, Martin U. Schuhmann, Jaishri O. Blakeley, Scott R. Plotkin, Christian Hagel, Victor F. Mautner

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth

    NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth 由 Marianne F. James, Sangyeul Han, Carolyn Polizzano, Scott R. Plotkin, Brendan D. Manning, Anat Stemmer‐Rachamimov, James F. Gusella, Vijaya Ramesh

    出版 2009
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Achieving consensus for clinical trials

    Achieving consensus for clinical trials 由 Scott R. Plotkin, Jaishri O. Blakeley, Eva Dombi, Michael J. Fisher, C. Oliver Hanemann, Karin S. Walsh, Pamela L. Wolters, Brigitte C. Widemann

    出版 2013
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  16. 16
    Treatment of Relapsed Central Nervous System Lymphoma with High-Dose Methotrexate

    Treatment of Relapsed Central Nervous System Lymphoma with High-Dose Methotrexate 由 Scott R. Plotkin, Rebecca A. Betensky, Fred H. Hochberg, Stuart A. Grossman, Glenn J. Lesser, Burt Nabors, Brian H. Chon, Tracy T. Batchelor

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors

    Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors 由 Hon Kit Wong, Johanna Lahdenranta, Walid S. Kamoun, Annie W. Chan, Andrea I. McClatchey, Scott R. Plotkin, Rakesh K. Jain, Emmanuelle di Tomaso

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Relationship between whole‐body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis

    Relationship between whole‐body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis 由 Vanessa L. Merker, Miriam A. Bredella, Wenli Cai, Ara Kassarjian, Gordon J. Harris, Alona Muzikansky, Rosa Nguyen, Victor F. Mautner, Scott R. Plotkin

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Self-reported access to specialty clinics and receipt of health surveillance among U.S. patients with neurofibromatosis 1: a national survey

    Self-reported access to specialty clinics and receipt of health surveillance among U.S. patients with neurofibromatosis 1: a national survey 由 Vanessa L. Merker, Yidan Ma, Lori B. Chibnik, Heather B. Radtke, Kate Kelts, Kaleb Yohay, Nicole J. Ullrich, Scott R. Plotkin, Justin T. Jordan

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Use of Video to Facilitate End-of-Life Discussions With Patients With Cancer: A Randomized Controlled Trial

    Use of Video to Facilitate End-of-Life Discussions With Patients With Cancer: A Randomized Controlled Trial 由 Areej El‐Jawahri, Lisa Podgurski, April F. Eichler, Scott R. Plotkin, Jennifer S. Temel, Susan L. Mitchell, Yuchiao Chang, Michael J. Barry, Angelo E. Volandes

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: